2015
DOI: 10.18267/j.pep.550
|View full text |Cite
|
Sign up to set email alerts
|

The Poor or the Kids? Distributional Impacts of Taxes and Benefits Among Czech Households

Abstract: Abstract:This paper provides an up-to-date analysis of the redistributive eff ects of the Czech tax and benefi t system at the household level. We provide several measures of the extent in which the tax and benefi t system redistributes from the rich to the poor and from the childless households to the households with children. We fi nd a rather weak combined power of the tax and benefi t systems in alleviating income inequalities. The system redistributes primarily towards households with children. While hous… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0
3

Year Published

2015
2015
2018
2018

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 7 publications
1
3
0
3
Order By: Relevance
“…These results were confirmed in both the univariate analysis and in the multivariable Cox model adjusted for possible confounding factors. The observation that patient age does not significantly influence PFS and OS of mCRC patients is consistent with previously published reports [11-14]. Thus, patient age should not be considered a limiting factor with respect to bevacizumab-containing therapy in mCRC patients.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…These results were confirmed in both the univariate analysis and in the multivariable Cox model adjusted for possible confounding factors. The observation that patient age does not significantly influence PFS and OS of mCRC patients is consistent with previously published reports [11-14]. Thus, patient age should not be considered a limiting factor with respect to bevacizumab-containing therapy in mCRC patients.…”
Section: Discussionsupporting
confidence: 91%
“…Efficacy and safety of bevacizumab administered in combination with chemotherapy backbone regimens in patients with mCRC have been the subject of several randomised clinical trials [5-7] as well as observational studies [8,9]. Although patients ≥65 years of age represent the majority of patients with mCRC, this patient population is often underrepresented in clinical trials and very likely undertreated in the clinical practice [10,11]. However, the results of recently published randomised trials as well as observational studies [12-15] suggest that bevacizumab provides similar overall survival (OS) and progression-free survival (PFS) benefits in patients aged ≥65 years compared to younger patients.…”
Section: Introductionmentioning
confidence: 99%
“…Immervoll (2004) nebo Galuščák a Pavel (2012) se zaměřují pouze na zaměstnance. 5 Dušek, Kalíšková, Münich (2013, 2014 b) Sociální a zdravotní pojištění -zaměstnanci a zaměstnavatelé • Sazba zdravotního pojistného placeného zaměstnancem se zvýší ze 4,5 % na 6,5 %.…”
Section: Reforma Přímých Daní 2015unclassified
“…Pro detailní popis modelu, jeho předpoklady, přesné defi nice daňových sazeb, a rozdělení daňových sazeb v aktuálním daňovém a dávkovém systému odkazujeme na předchozí články (Dušek, Kalíšková, a Münich 2013, 2014) a na on-line appendix. 10 Zde pouze shrnujeme hlavní koncepty.…”
Section: Model Taxbenunclassified
“…Detailní popis modelu Taxben včetně výsledných simulací současného daňového a sociálního systému je možné nalézt ve studiích Dušek, Kalíšková a Münich (2013a, 2013b.…”
unclassified